Superworth

Bausch & Lomb PE ratio BLCO

Share price divided by earnings per share over the last twelve months, since 2021.

Today, Oct 23, 2026
n/m
losses over the last year
Earnings per share, 12 months
−$0.48
to Jun 30, 2026
Share price
$17.47
Oct 23, 2026
Peer median
31.6×

Bausch & Lomb has no meaningful PE ratio today: it lost $0.48 a share over the last twelve months, and a PE needs earnings.

It has had no meaningful PE for most of its history, so the chart below shows the earnings per share a PE divides the price by.

Earnings per share over time

A PE divides the share price by these earnings. While they were a loss or a sliver, the PE meant nothing, so this chart shows the earnings themselves.

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$1.02n/a
FY2024−$0.91n/a
FY2023−$0.74−3800%
FY2022$0.02−96%
FY2021$0.53n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.04n/a−$0.48
Q1 FY26−$0.20n/a−$0.62
Q4 FY25−$0.16n/a−$1.02
Q3 FY25−$0.08−900%−$0.87
Q2 FY25−$0.18n/a−$0.78
Q1 FY25−$0.60n/a−$1.03
Q4 FY24−$0.01n/a−$0.91
Q3 FY24$0.01n/a−$1.05
Q2 FY24−$0.43n/a−$1.30
Q1 FY24−$0.48n/a−$0.96
Q4 FY23−$0.15n/a−$0.74
Q3 FY23−$0.24n/a−$0.59

Against its peers

Companies in Medical - Instruments & Supplies nearest Bausch & Lomb's size, closest first, today.

CompanyPE ratio
BLCOBausch & Lombn/m
MMSIMerit Medical Systems38.6×
MSAMSA Safety22.7×
HAEHaemonetics58.1×
VNTVontier14.3×
BMIBadger Meter35.3×
ICUIICU Medical141×
NVSTEnvista40.7×
PODDInsulet27.9×
GMEDGlobus Medical20.8×
ALGNAlign Technology26.9×
Peer median31.6×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on Bausch & Lomb

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.